Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 4
2004 5
2005 7
2006 4
2007 9
2008 19
2009 24
2010 18
2011 25
2012 25
2013 28
2014 28
2015 36
2016 34
2017 37
2018 73
2019 86
2020 70
2021 76
2022 111
2023 104
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

764 results

Results by year

Filters applied: . Clear all
Page 1
A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma.
Ju WT, Xia RH, Zhu DW, Dou SJ, Zhu GP, Dong MJ, Wang LZ, Sun Q, Zhao TC, Zhou ZH, Liang SY, Huang YY, Tang Y, Wu SC, Xia J, Chen SQ, Bai YZ, Li J, Zhu Q, Zhong LP. Ju WT, et al. Among authors: zhu q. Nat Commun. 2022 Sep 14;13(1):5378. doi: 10.1038/s41467-022-33080-8. Nat Commun. 2022. PMID: 36104359 Free PMC article. Clinical Trial.
Interleukins and Psoriasis.
Zhu Q, Zhao L, Ding H, Song J, Zhang Q, Yu S, Wang Y, Wang H. Zhu Q, et al. J Cutan Med Surg. 2024 Feb 5:12034754241227623. doi: 10.1177/12034754241227623. Online ahead of print. J Cutan Med Surg. 2024. PMID: 38314729 Review.
Natural Killer Cell-targeted Immunotherapy for Cancer.
Tang J, Zhu Q, Li Z, Yang J, Lai Y. Tang J, et al. Among authors: zhu q. Curr Stem Cell Res Ther. 2022;17(6):513-526. doi: 10.2174/1574888X17666220107101722. Curr Stem Cell Res Ther. 2022. PMID: 34994316 Review.
764 results